Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.12.2021 | Case report

Letermovir/tacrolimus interaction

Increase in tacrolimus trough concentrations due to drug-drug interaction and off label use: 7 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
  • * Drug interaction
Literatur
Zurück zum Zitat Jorgenson MR, et al. The addition of adjunctive letermovir to valganciclovir for refractory cytomegalovirus viremia in kidney transplant recipients. Transplant Infectious Disease 23: No. 4, Aug 2021. Available from: URL: http://doi.org/10.1111/tid.13693 Jorgenson MR, et al. The addition of adjunctive letermovir to valganciclovir for refractory cytomegalovirus viremia in kidney transplant recipients. Transplant Infectious Disease 23: No. 4, Aug 2021. Available from: URL: http://​doi.​org/​10.​1111/​tid.​13693
Metadaten
Titel
Letermovir/tacrolimus interaction
Increase in tacrolimus trough concentrations due to drug-drug interaction and off label use: 7 case reports
Publikationsdatum
01.12.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-06570-0

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Tadalafil

Case report

Arsenic-trioxide

Case report

Methotrexate